Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis [3]

American Journal of Gastroenterology

Volumn 101, Issue 11, 2006, Pages 2664-2665

  Peyrin Biroulet, Laurent ^a   Bressenot, Aude ^a   Chone, Laurence ^a   Denjean, Philippe ^a   Boissel, Patrick ^a   Bigard, Marc André ^a   Bronowicki, Jean Pierre ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; INFLIXIMAB; STEROID; TACROLIMUS;

ADULT; ANAMNESIS; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; LETTER; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; METASTASIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; SCLEROSING CHOLANGITIS;

ADENOCARCINOMA; ADULT; ANTIBODIES, MONOCLONAL; CECAL NEOPLASMS; CHOLANGITIS, SCLEROSING; COLONIC NEOPLASMS; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS;

EID: 33750530178     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00809_3.x     Document Type: Letter

References (5)

1. Biancone L, Orlando A, Kohn A, et al. Infliximab does not increase the risk of newly diagnosed neoplasia in Crohn's disease : A multicenter matched-pair study. Gut 2006;55:228-33.
2. Loftus EV Jr, Aguilar HI, Sandborn WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998;27:685-90.
3. Bleday R, Lee E, Jessurun J, et al. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993;36:908-12.
4. Narumi S, Roberts JP, Emond JC, et al. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22:451-7.
5. Vera A, Gunson BK, Ussatoff V, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003;75:1983-8.